Who was studied, and how
Four numbers in the abstract
Where each one falls
Where it lands on the map
7,850people in the Glycemia Reduction Approaches in Diabetes trial, from 2013
4,980of them with cardiovascular disease, in this paper
The trial randomly assignedassigned by chance
liraglutide
the rest
Lowered weight change during the first year−3.50
randomisedThe trial randomly assignedassigned by chance
sitagliptin
the rest
Lowered weight change during the first year−1.07
randomisedthe abstract, start to end
… change (kg) during the first year was -3.5 (-3.8,-3.2) with liraglutide,-1.07 (-1.4,-0.78) with sitagliptin, 0.45 (0.16, 0.74) with glargine, and 0.89 (0.60, 1.2) with glimepiride (P …
← favours treatmentfavours comparator →
could be chanceWeight change (kg) during the first yearliraglutide
−3.5−3.80 to −3.20
Weight change (kg) during the first yearsitagliptin
−1.07−1.40 to −0.78
Weight change (kg) during the first yearglargine
0.450.16–0.74
Weight change (kg) during the first yearglimepiride
0.890.60–1.20
GLP-1 receptor agonistsDPP-4 inhibitorsSulfonylureas & glinidesInsulinBody weight & composition
1 / 4